Yousef H Aldebasi Selected Research

Yousef H Aldebasi Research Topics

5	Neoplasms (Cancer) 04/2019 - 01/2013
3	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2014
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2013 - 01/2013
1	Inflammation (Inflammations) 09/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 09/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Infections 01/2018
1	Candidiasis (Moniliasis) 01/2018
1	Hyperglycemia 01/2018
1	Body Weight (Weight, Body) 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017
1	Diabetes Mellitus 01/2017
1	Fibrosarcoma 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2014
1	Corneal Injuries 11/2013
1	Neuroinflammatory Diseases 08/2013
1	Carcinoma (Carcinomatosis) 01/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013
1	Disease Progression 01/2013

3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020 - 12/2014
3	Liposomes (Liposome)IBA 01/2020 - 01/2015
2	AntioxidantsIBA 09/2021 - 12/2013
2	thymoquinoneIBA 04/2019 - 01/2018
1	CatalaseIBA 09/2021
1	CarnosineIBA 09/2021
1	LipidsIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Gentian Violet (Violet, Crystal)FDA Link 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2019
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Therapeutic UsesIBA 01/2018
1	SuspensionsIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	benz(a)anthracene (benzanthracene)IBA 01/2015
1	liposomal doxorubicin (Doxil)FDA Link 01/2015
1	GlycosphingolipidsIBA 01/2015
1	ResveratrolIBA 12/2014
1	Annexin A5IBA 12/2014
1	human ERBB2 proteinIBA 12/2014
1	PeroxidasesIBA 05/2014
1	CurcuminIBA 12/2013
1	Artemether FDA Link 08/2013
1	Chloroquine (Aralen)FDA LinkGeneric 08/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013